Universal-Bac3Gel: a 3D Biofilm-Relevant Matrix that Supports In Vitro Growth and Biofilm Formation of ESKAPE Pathogens.
Emanuela PelusoiD, Sebastião van UdeniD, Sonja VisentiniD, Paola PetriniiD, Daniela Peneda PachecoiD, Livia VisaiiD
Abstract
Human microbiota is increasingly considered to shape health and disease, drawing interest of pharma and biotech industries in advanced models of in vitro human microbiome to streamline drug development. In this context, Universal-Bac3Gel(R) represents a new generation of 3D biomaterials designed to mimic the properties of human mucus and biofilm features, including micro-gradients that replicate the heterogeneous environments colonized by microorganisms in the human body. To evaluate the suitability of Universal-Bac3Gel(R) for studying clinically relevant species in antimicrobial resistance, the so-called ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae) were cultured within this 3D environment. Bacterial growth was monitored at 24- and 48-hours post-inoculation via spot plating, while viability, distribution and organization were assessed using confocal laser scanning microscopy. All ESKAPE strains successfully grew throughout the structure of Universal-Bac3Gel(R). Distinct 3D biofilm architectures were observed across species, ranging from diffuse colonization to compact microcolony formation, in agreement with species-specific biofilm patterns. Notably, the platforms ready-to-use 96-well format allowed direct comparison of these high-priority pathogens under identical conditions, highlighting species-specific biofilm traits that would be difficult to discern in traditional 2D or animal models. This work highlights the versatility of Universal-Bac3Gel(R) as a platform for studying pathogen colonization under a biofilm-relevant environment and underscores its potential for translational applications, including antimicrobial drug testing, personalized medicine, and reduction of animal model use in preclinical research.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 49%
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cross-linked agarose-gelatine beads as a substrate for investigating biofilms of bacterial pathogens
Dan Roizman, Maren Herzog, … Alexandro Rodríguez-Rojas·BiofilmPeer-reviewed·Jul 9, 2026
- Inkjet based 3D Printing of bespoke medical devices that resist bacterial biofilm formation
Y. He, B. Begines, … R. D. Wildman·bioRxiv·Jun 30, 2020
- BiDBiC: A novel ultra-high-throughput pipeline for Bead-in-Droplet Biofilm Cultivation and Characterization
Jessica Du Li, Xiaoxia Nina Lin·bioRxiv·Jun 19, 2026
- Biofilm Growth Under Elastic Confinement
R. E. Goldstein, G. T. Fortune, N. M. Oliveira·bioRxiv·Dec 5, 2021
- Surface Energy and Viscoelastic Characteristics of Staphylococcus epidermidis and Cutibacterium acnes Biofilm on Commercial Skin Constructs versus Agar
S. A. Razgaleh, A. Wrench, A.-A. D. Jones·bioRxiv·Feb 10, 2023
- Mechanoregulation of biofilm architecture promotes Pseudomonas aeruginosa antibiotic tolerance.
A. Cont, J. Vermeil, A. Persat·bioRxiv·Feb 16, 2022